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Abstract
Introduction: Intra-aortic balloon occlusion (IABO) is useful for proximal vascular control, by clamping the
descending aorta, in traumatic haemorrhagic shock. However, there are limited clinical studies regarding its
effectiveness. This study aimed at investigating the effectiveness of IABO for traumatic haemorrhagic shock.
Methods: This retrospective, observational study included trauma patients who underwent IABO at the Emergency
and Critical Care Center of Nippon Medical School Tama-Nagayama Hospital between January 2009 and March 2013.
14 patients were included to this study who were in shock on arrival (systolic blood pressure [SBP] <90 mmHg or shock
index ≥1), underwent IABO for resuscitation and temporary haemostasis, and subsequently underwent haemostatic
intervention (operation or transcatheter arterial embolization). Patient characteristics, physiological status, SBP, heart rate
(HR), initial fluid and blood transfusion, time course, and total occlusion time were compared before and after IABO as
well as between the survived (n = 5) and non-survived (n = 9) groups.
Results: The majority of patients experienced blunt injuries, with an average injury severity score of 29.5. The liver, pelvis,
spleen, and mesenterium represented the majority of injured organs. SBP, but not HR, was significantly higher after IABO
than before IABO (123.1 vs. 65.5 mmHg, P = 0.0001). The revised trauma score and probability of survival were significantly
different between the survived and non-survived groups (both, P = 0.04). The survived group required significantly less
blood transfusion volume than the non-survived group (20 vs. 33.7 red blood cell units, P = 0.04). In addition, the survived
group required a significantly shorter total occlusion time than the non-survived group (46.2 vs. 224.1 min, P = 0.002).
Conclusions: IABO was used for relatively severe trauma patients. SBP was significantly higher after IABO, but was not
related to survival. However, blood transfusion volume and total occlusion time were related to survival; therefore, it is
important to reduce or shorten these parameters, i.e., immediate definitive haemostasis. IABO is effective for traumatic
haemorrhagic shock; however, it is also important to consider these points and potential complications.
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Introduction
It has been reported that an emergent laparotomy in in-
jured hypotensive patients with massive hemoperitoneum
frequently results in cardiac arrest as the abdominal wall
tamponade is released. Occlusion of the descending aorta
before laparotomy is reportedly necessary for proximal
vascular control [1,2] and can temporarily decrease intra-
abdominal bleeding and maintain blood flow to the brain
and heart.
Although left thoracotomy with direct clamping of the
descending aorta is considered the primary method, it is
very invasive, with reported complications such as anter-
ior spinal artery injury or persistent bleeding from inter-
costal arteries after recovery from shock. In comparison,
occlusion of the descending aorta by intra-aortic balloon
occlusion (IABO) is less invasive, and the inflation vol-
ume and duration can be controlled in response to vital
signs. As a result, the latter method is increasingly being
used.
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IABO, which was developed by Edwards et al. in 1953
[3], was initially intended for surgical treatment of abdom-
inal aortic aneurysms and was later applied to traumatic
haemorrhagic shock. It is reportedly effective not only for
blunt abdominal injuries but also for retro-peritoneal
haemorrhage from a pelvic fracture [4], penetrating ab-
dominal trauma [5], and non-traumatic cases such as
post-partum haemorrhage [6]. Stannard et al. described
the following IABO steps: (1) arterial access, (2) balloon
selection and positioning, (3) balloon inflation, (4) balloon
deflation, and (5) sheath removal [7].
The opportunities for IABO use are increasing; however,
there have been only a few case reports [6,8] or experimen-
tal studies of animal models (e.g., porcine and dog) [9-14].
Furthermore, there are limited clinical studies regarding its
effectiveness. Therefore, this study aimed to retrospectively
investigate the effectiveness of IABO for traumatic haemor-
rhagic shock based on our clinical experiences.
Materials and methods
Patients
This retrospective, observational study included trauma pa-
tients who underwent IABO at the Emergency and Critical
Care Center of Nippon Medical School Tama-Nagayama
Hospital between January 2009 and March 2013. Of all
trauma patients in this period (n = 540), 21 patients under-
went IABO without cardiopulmonary arrest on arrival.
Furthermore, 7 patients were excluded if the IABO was
inserted as a standby without inflation, inserted preventively
for non-shock patients and inflated during haemostatic
intervention. The remaining 14 patients were included to
this study who were in shock on arrival (systolic blood pres-
sure <90 mmHg or shock index ≥1), underwent IABO for
resuscitation and temporary haemostasis, and subsequently
achieved haemostatic intervention (operation or transcathe-
ter arterial embolization).
Indication and procedure
General indication of IABO in our hospital is haemor-
rhagic shock due to any of the following: (1) intra-
abdominal haemorrhage (e.g., liver or splenic injury); (2)
retroperitoneal haemorrhage (e.g., renal injury or pelvic
fracture); or (3) non-traumatic haemorrhage (e.g., obstet-
ric or gastrointestinal bleeding). In this study, we ana-
lysed only trauma patients in case of (1) and/or (2).
During the procedure, generally, the emergency physician
inserted the aortic occlusion balloon (Block Balloon™; Senko
Medical Instrument Mfg. Co., Ltd., Tokyo, Japan) without
radiographic assistance. A 10-Fr sheath was retained in the
femoral artery (generally left), the balloon catheter was
inserted above the bleeding point and >2 cm below the bi-
furcation of subclavian artery, and normal saline was
injected to inflate the balloon. The procedure was per-
formed with minimum inflation, with monitoring via blood
pressure in the upper arm, and minimal occlusion time,
achieved by incomplete or intermittent occlusion.
Data collection
Data were extracted from medical records. The 14 pa-
tients were divided into the survived group (n = 5) and
non-survived group (n = 9) based on the final recorded
outcome. Data regarding the patient characteristics and
physiological status in each group were collected. In
addition, systolic blood pressure (SBP), heart rate (HR),
initial fluid and blood transfusion, time course, and total
occlusion time before and after IABO were collected.
Base excess, body temperature, and prothrombin time
were collected from the initial data on arrival. Initial
fluid and blood transfusion represent the crystalloid vol-
ume and red blood cell (RBC) units within 24 hours of
arrival, respectively. The injury severity score, revised
trauma score (RTS), and probability of survival (Ps) were
calculated with commonly used formulas.
Statistical analysis
Patient characteristics, physiological status, SBP, HR, ini-
tial fluid and blood transfusion, time course, and total
occlusion time were compared between pre- and post-
IABO as well as between the survived group (n = 5) and
Table 1 Characteristics of trauma patients who
underwent intra-aortic balloon occlusion
Values for the entire sample
(n = 14)
Age (years) 46.9 ± 5.2
Sex (Men:Women) 10:4
Mechanism of injury (Blunt:Stabbing) 13:1







ISS 29.5 ± 3.6
RTS 5.414 ± 0.308
Ps 0.62 ± 0.09
Location of insertion (n)
Emergency room 14
Vascular approach
Right femoral artery 7
Left femoral artery 7
The primary injured organ was defined as the main bleeding organ.
ISS, injury severity score; RTS, revised trauma score; Ps, probability of survival.
Values are mean ± SE.
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non-survived group (n = 9) using Wilcoxon signed rank
tests and Mann-Whitney U tests, respectively. Statistical
analyses were conducted using GraphPad Prism 6




The mean age was 46.9 years old, 71% of the patients
were men, and the majority experienced blunt injuries
(Table 1).
Physiological status
Of the measures for physiological status, significant dif-
ferences were only present between the survived and
non-survived groups in the RTS and Ps (both, P = 0.04;
Table 2).
Systolic blood pressure and heart rate
SBP was significantly higher after IABO than before
IABO, in the entire sample (123.1 ± 10.5 vs. 65.5 ± 4.7
mmHg, P = 0.0001) (Figure 1A). Between the survived
and non-survived groups, the change in SBP (ΔSBP)
was not significantly different (65.8 ± 17.1 vs. 53.1 ± 15.6
mmHg, P = 0.517) (Figure 1B).
The HR after IABO was not significantly different
from that before IABO (98.4 ± 5.7 vs. 109.9 ± 4.5 beats
per minute [BPM], P = 0.051) (Figure 2A). The change
in HR (ΔHR) was also not significantly different between
the survived and non-survived groups (-5.8 ± 10.9
vs. -14.8 ± 6.7 BPM, P = 0.79) (Figure 2B).
Initial fluid and blood transfusion
The initial fluid transition was not significantly different
between the survived and non-survived groups (2250 ±
512 vs. 2083 ± 417 mL, P = 0.595) (Figure 3A). However,
the survived group required a significantly lower blood
volume than the non-survived group (20.0 ± 3.4 vs. 33.7 ±
3.9 RBC units, P = 0.04) (Figure 3B).
Time course and total occlusion time
The comparisons of time course and total occlusion
time are shown in Figures 4 and 5.
Between the survived and non-survived groups, there
were no significant differences in time from injury to
IABO insertion (107.2 ± 17.9 vs. 98.7 ± 7.2 min, P = 0.923)
(Figure 4A), time from arrival to IABO insertion (68.4 ±
18.1 vs. 57.9 ± 6.9, P = 0.771) (Figure 4B), or time from
IABO insertion to the start of the intervention (52.6 ± 8.2
vs. 42.8 ± 6.3, P = 0.495) (Figure 4C). However, there was a
significantly shorter total occlusion time in the survived
Table 2 Physiological status of trauma patients who underwent IABO, based on survival
Survived (n = 5) Non-survived (n = 9) P value
Age (years) 33.6 ± 4.8 54.3 ± 6.5 0.079
ISS 26.0 ± 6.3 31.4 ± 4.6 0.498
RTS 6.280 ± 0.306 4.933 ± 0.364 0.04
Ps 0.86 ± 0.06 0.48 ± 0.11 0.04
Base excess (mmol/L) -4.9 ± 2.0 -13 ± 2.9 0.064
Body temperature (°C) 34.9 ± 0.34 35.7 ± 0.31 0.191
Prothrombin time (%) 75.1 ± 11.1 60.5 ± 10.5 0.521
ISS, injury severity score; RTS, revised trauma score; Ps, probability of survival.
Values are mean ± SE.
Figure 1 Comparison of systolic blood pressure (SBP) of trauma patients who underwent intra-aortic balloon occlusion (IABO). A:
Comparison of SBP before and after IABO in all cases (n = 14). B: Comparison of the change in SBP (ΔSBP) between the survived group (n = 5)
and non-survived group (n = 9). Values are reported as mean ± SE, analysed using a Wilcoxon signed rank test (A) or Mann-Whitney U test (B).
*P < 0.05, **P < 0.01, ***P < 0.001.
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group than in the non-survived group (46.2 ± 15.0 vs.
224.1 ± 52.1 min, P = 0.002) (Figure 5).
Discussion
This study demonstrated that IABO was used for rela-
tively severe trauma patients, with an significant increase
in SBP after IABO. Similar effects have been shown in
other the majority of reports, indicating that IABO is ef-
fective for achieving hemodynamic stability. However,
based on the significant differences in the blood transfu-
sion volume within 24 hours after arrival between sur-
vived and non-survived groups, IABO might only have a
temporary haemostatic effect. If definitive haemostasis is
not achieved, additional blood transfusion is required,
with poorer outcomes.
Therefore, survival depends on lower blood transfu-
sion volumes, by immediate definitive haemostasis, and
shorter total occlusion times, by deflating the IABO. It
should be noted that poorer outcomes may result from
delayed definitive haemostasis, which could occur be-
cause of a sense of comfort from the temporary im-
provement of haemodynamics by IABO. For example,
enhanced computed tomography (CT) is often used to
search for injury sites, but this could unnecessarily delay
definitive haemostasis. Actually we performed enhanced
CT after IABO 1 of 5 in survived group and 4 of 9 in
non-survived group. Each occlusion time was over 200
minutes in non-survived patients who performed CT.
However, the situation may differ by hospital; time is re-
quired for the procedure, and IABO has to be deflated
temporarily for the injection of contrast medium. As a
result, there is a risk that haemodynamics could worsen.
Although enhanced CT is necessary when the point of
bleeding is unclear and the search for retroperitoneal
haemorrhage is unavoidable, the time should be as short
as possible.
Physiological status of survived or non-survived pa-
tients indicates that IABO was used for relatively more
severe trauma patients. Although blood pressure was
significantly higher after IABO, it does not appear to be
related to survival or have an effect on shock.
Regarding the time course of IABO insertion, it does
not appear to be related to survival. Therefore, IABO
does not have to be inserted immediately after arrival
nor does the intervention need to immediately follow
IABO insertion. Instead, the total occlusion time is more
important for survival outcomes, as already discussed.
Although patients who were not experiencing shock
and underwent IABO for preventive reasons were ex-
cluded from this study, we experienced a case of a 46-
Figure 2 Comparison of heart rate (HR) of trauma patients who underwent intra-aortic balloon occlusion (IABO). A: Comparison of HR
before and after IABO in all cases (n = 14). B: Comparison of the change in HR (ΔHR) between the survived group (n = 5) and non-survived group
(n = 9). Values are reported as mean ± SE, analysed using a Wilcoxon signed rank test (A) or Mann-Whitney U test (B).
Figure 3 Comparison of initial fluid and blood transfusion in trauma patients who underwent intra-aortic balloon occlusion (IABO). A:
Comparison of initial fluid (crystalloid volume within 24 hours of arrival) between the survived group (n = 5) and non-survived group (n = 9). B:
Comparison of blood transfusion (red blood cell [RBC] units within 24 hours of arrival) requirements between the survived group (n = 5) and
non-survived group (n = 9). Values are reported as mean ± SE, analysed using a Mann-Whitney U test. *P < 0.05.
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year-old man with an abdominal stab wound in which
IABO was extremely effective for maintaining a good field
of operation. His haemodynamics were stable, but IABO
was inserted to prevent massive intraoperative bleeding.
During the laparotomy, we identified that the stab wound
entered the left liver lobe. When the knife was removed,
arterial bleeding was observed and controlled by inflation
of IABO; as a result, we could complete the liver suture
with a good field of view. This effect might be significant
for shortening the time to definitive haemostasis. There-
fore, we recommend considering IABO for prevention in
non-shock cases. For cases that do not present with shock
immediately but may experience shock later, it may be
best to detain only the sheath initially and be ready to im-
mediately insert an IABO, when necessary.
The major complications of IABO are considered to
be aortic injury, dissection, ischemia and reperfusion in-
jury of lower part organs, and thrombosis; therefore, the
contraindications include a dissecting aneurysm, signifi-
cant aortic meandering or calcification, and a bleeding
point located above the balloon. On the other hand, it
has been reported that complications do not occur with
IABO for blunt and penetrating injuries [8]. We also did
not experience any aortic injury when we insert IABO
blindly not use under radiography. Sovik et al reported
that IABO has been used without fluoroscopy in patients
with post- partum haemorrhage, and 1 of 6 patients ex-
perienced an aortic rupture necessitating surgical repair
[6]. Although we also seldom use radiography, it might
be helpful to prevent aortic injury. Furthermore we need
carefully caution with distal organ ischemia at occlusion
point. Markov et al. reported renal dysfunction and liver
necrosis have been observed in a swine model at 90 mi-
nutes of IABO occlusion; however, this was not related
to mortality [12]. In addition, marked splanchnic ische-
mia during aortic occlusion has been reported in a dog
model [14]. We had only one patient with slight renal
dysfunction. In this case, the total occlusion time was 37
Figure 4 Comparison of the time course in trauma patients who underwent intra-aortic balloon occlusion (IABO). A: Comparison of time
from injury to IABO insertion between the survived group (n = 5) and non-survived group (n = 9); B: Comparison of time from arrival to IABO
insertion between the survived group (n = 5) and non-survived group (n = 9); C: Comparison of time from IABO insertion to intervention start
between the survived group (n = 5) and non-survived group (n = 9). Values are reported as mean ± SE, analysed using a Mann-Whitney U test.
Figure 5 Comparison of total occlusion time in trauma patients
who underwent intra-aortic balloon occlusion (IABO), between
the survived group (n = 5) and non-survived group (n = 9). Values
are reported as mean ± SE, analysed using a Mann-Whitney U test.
*P < 0.05, **P < 0.01, ***P < 0.001.
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minutes (incomplete occlusion), and the blood urea ni-
trogen/creatinine increased to 31.1/1.97 and was im-
proved only by fluid infusion. Although it was not a
serious complication, it was likely due to ischemia from
IABO; therefore, attention should be paid to this poten-
tial complication.
However, limited data from well-organized studies are
available, and empirical descriptions indicate that approxi-
mately 45 minutes is the limit. It would be helpful to have
a staff to manage the balloon and try to minimize incom-
plete or intermittent occlusion for the maintenance of
blood pressure. Moreover, the range of occlusion should
be narrowed, e.g., occlusion below the bifurcation of renal
arteries in case of pelvic fracture. In addition, the sheath
should be as thin as possible. In Japan, a 10-Fr sheath is
widely used, but a 7-Fr sheath was recently developed
(RESCUE BALLOON®; Tokai Medical Products Inc.,
Tokyo, Japan) and used clinically.
This study has certain limitations. This study was not a
randomized, controlled trial, which may have introduced
bias; furthermore, the severity of the patients who sur-
vived and who were non-survived was not the same. How-
ever, as IABO tends to be used in emergency situations, it
is practically difficult to perform a randomized trial. Add-
itional multicentre studies are required to determine the
effectiveness of this device.
Conclusions
Based on our results relating to the effectiveness of IABO
for traumatic haemorrhagic shock, a reduction in blood
transfusion volume and shorter total occlusion times (i.e.,
immediate definitive haemostasis) are important for survival.
IABO is an effective device to treat traumatic haemorrhagic
shock; however, these recommendations and awareness of
potential complications are necessary for success.
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